Evaluation of Reference Regions for (R)-[11C]PK11195 Studies in Alzheimer's Disease and Mild Cognitive Impairment

Inflammation in Alzheimer's disease (AD) may be assessed using (R)-[11C]PK11195 and positron emission tomography. Data can be analyzed using the simplified reference tissue model, provided a suitable reference region is available. This study evaluates various reference regions for analyzing (R)-[11C]PK11195 scans in patients with mild cognitive impairment (MCI) and probable AD. Healthy subjects (n = 10, 30 ± 10 years and n = 10, 70 ± 6 years) and patients with MCI (n = 10, 74 ± 6 years) and probable AD (n = 9, 71 ± 6 years) were included. Subjects underwent a dynamic three-dimensional (R)-[11C]PK11195 scan including arterial sampling. Gray matter, white matter, total cerebellum and cerebrum, and cluster analysis were evaluated as reference regions. Both plasma input binding potentials of these reference regions (BPPLASMA) and corresponding reference region input binding potentials of a target region (BPSRTM) were evaluated. Simulations were performed to assess cluster analysis performance at 5% to 15% coefficient of variation noise levels. Reasonable correlations for BPPLASMA (R2 = 0.52 to 0.94) and BPSRTM (R2 = 0.59 to 0.76) were observed between results using anatomic regions and cluster analysis. For cerebellum white matter, cerebrum white matter, and total cerebrum a considerable number of unrealistic BPSRTM values were observed. Cluster analysis did not extract a valid reference region in 10% of the scans. Simulations showed that potentially cluster analysis suffers from negative bias in BPPLASMA. Most anatomic regions outperformed cluster analysis in terms of absence of both scan rejection and bias. Total cerebellum is the optimal reference region in this patient category.

[1]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[2]  Yuji Nagai,et al.  Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.

[3]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[4]  H. Kung,et al.  Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Gert Luurtsema,et al.  Optimizing an online SPE-HPLC method for analysis of (R)-[11C]1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide [(R)-[11C]PK11195] and its metabolites in humans. , 2005, Nuclear medicine and biology.

[6]  Eric Achten,et al.  Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography , 2003, European Neurology.

[7]  Ronald Boellaard,et al.  Evaluation of Methods for Generating Parametric (R)-[11C]PK11195 Binding Images , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Elizabeth L Sampson,et al.  In vivo detection of microglial activation in frontotemporal dementia , 2004, Annals of neurology.

[9]  R B Banati,et al.  [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.

[10]  W. J. Lorenz,et al.  Performance evaluation of the whole-body PET scanner ECAT EXACT HR + , 1997 .

[11]  N L Foster,et al.  PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  B. Gulyás,et al.  Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[14]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[15]  R. Myers,et al.  Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury , 2001, Neuroreport.

[16]  G Brix,et al.  Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Guy Marchal,et al.  Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.

[18]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[19]  R B Banati,et al.  Mills’ and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  Ronald Boellaard,et al.  Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET , 2001, European Journal of Nuclear Medicine.

[21]  Ryuji Nakao,et al.  Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  R. Boellaard,et al.  Evaluation of Reference Tissue Models for the Analysis of [11C](R)-PK11195 Studies , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  F. Turkheimer,et al.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  G. Glatting,et al.  Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.

[25]  Gerald Q. Maguire,et al.  Comparison and evaluation of retrospective intermodality brain image registration techniques. , 1997, Journal of computer assisted tomography.

[26]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[27]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[28]  R B Banati,et al.  In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. , 2001, Brain : a journal of neurology.

[29]  Ronald Boellaard,et al.  Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  B. Gulyás,et al.  [11C]Vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies , 2005, Journal of the Neurological Sciences.

[31]  C. C. Watson,et al.  New, faster, image-based scatter correction for 3D PET , 1999, 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).

[32]  F. Turkheimer,et al.  Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.

[33]  J. Korf,et al.  In vivo evaluation in mice and metabolism in blood of human volunteers of [123I]iodo-PK11195: a possible single-photon emission tomography tracer for visualization of inflammation , 1999, European Journal of Nuclear Medicine.

[34]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[35]  Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study. , 2002, Nuclear medicine and biology.

[36]  S. Hume,et al.  Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. , 1994, Nuclear medicine and biology.

[37]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[38]  B. Kiss,et al.  PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects , 2002, Acta neurologica Scandinavica.

[39]  Christopher J. Taylor,et al.  A cluster analysis approach for the characterization of dynamic PET data , 1996 .

[40]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.